Business
Easton Pharmaceuticals Announces Preparations for North American Product(s) Launch
Easton Pharmaceuticals Announces Preparations for North American Product(s) Launch.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Announces Preparations for North American Product(s) Launch\n \n \nEaston Pharmaceuticals Announces Preparations for North American Product(s) Launch\n \n TORONTO, ON--(Marketwired - Sep 15, 2014) - Easton Pharmaceuticals (OTC: EAPH) Announces it has finalized and prepares for the launch of 3 initial OTC therapeutic products and other additional products for a marketing and sales launch.\n As announced, Easton has previously received all required ingredients and has readied 3 of its main OTC therapeutic products which are VIORRA TM, SKIN RENOU HA, and KENESTRIN GEL. The 3 products will be made immediately available once packaging is delivered which involves containers and labeling. Included with the 3 initial Easton products are an additional 3 cosmetic products as a result of an agreement with a Toronto, Canada based manufacturer who will manufacture and supply the U.S. and Canadian markets. The line of products will be formally announced in the next few short weeks which is expected to be in conjunction with a marketing plan and partner who have been in discussions with the company over the past month for U.S. and Canadian distribution. The new marketing partner will be replacing the previous agreement signed with Global Links (OTC: GLCO) following Easton's termination of the agreement originally signed in May of 2014. \n The missing packaging and labeling component is only expected to take 2 weeks for completion. Products are expected to be available for sale within the next 30 to 45 days in preparation for the upcoming Christmas buying season on Easton's website as well as multiple distributors as part of a comprehensive marketing strategy. Full details to be made shortly available. The initial products being launched, VIORRA TM, SKIN RENOU HA, and KENESTRIN GEL are expected to command a lucrative minimum gross margin of 40-50% at a wholesale level, which is considered very conservative. Detailed retail pricing will be announced on launch date.\n VIORRA ™ = (Will service a broad female market including a growing ageing female population, but can also be utilized by younger woman to assist in naturally treating FSAD and lack of lubricity, a condition affecting millions of women of different ages. )\n SKIN RENOU HA = ( A product to service the multi billion dollar anti wrinkle cosmeti...